David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon

Analyst Articles

For the millions of Americans who suffer from high cholesterol, Nov. 30 will be a big day. That’s when Pfizer’s (NYSE: PFE) blockbuster drug Lipitor will lose patent protection, promising massive savings for high-cholesterol patients. The $7 billion drug (according to projected 2011 sales) also represents a big deal for… Read More

The brutal market swoon has reminded us of an oft-repeated lesson: even the best companies can get swept up in a downdraft. This across-the-board selling, frequently the result of an economic slowdown, can end up revealing a clear chasm. On the one side are companies that would indeed run into… Read More

The massive government stimulus measures passed by the U.S. Congress in 2009 and 2010 enabled states to continue their work on major municipal projects. New highway spurs were completed, roadbeds were repaved and creaking bridges were shored-up. This not only provided work for individuals at a time when unemployment figures… Read More

“Bolsa de Valores, Mercadorias & Futuros de Sao Paulo” You may not know this Portuguese title. You may not even know it by its shortened moniker, “The Bovespa.” But you should. This is because it is the equivalent of Wall Street for South America. Indeed, the Brazilian… Read More